Macrogenics Inc (MGNX)
3.21
-0.07
(-2.13%)
USD |
NASDAQ |
Nov 21, 16:00
3.39
+0.18
(+5.61%)
After-Hours: 20:00
Macrogenics Gross Profit Margin (Quarterly): 98.31% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 98.31% |
| June 30, 2024 | 73.85% |
| March 31, 2024 | 76.76% |
| December 31, 2023 | 98.22% |
| September 30, 2023 | 67.69% |
| June 30, 2023 | 91.04% |
| March 31, 2023 | 85.62% |
| December 31, 2022 | 97.48% |
| Date | Value |
|---|---|
| September 30, 2022 | 92.47% |
| June 30, 2022 | 90.76% |
| March 31, 2022 | 99.55% |
| December 31, 2021 | 92.33% |
| September 30, 2021 | 89.37% |
| June 30, 2021 | 99.93% |
| March 31, 2021 | 99.89% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
67.69%
Minimum
Sep 2023
99.93%
Maximum
Jun 2021
90.22%
Average
92.33%
Median
Dec 2021
Gross Profit Margin (Quarterly) Benchmarks
| KORU Medical Systems Inc | 63.40% |
| Apellis Pharmaceuticals Inc | 82.95% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -77.40% |
| Return on Assets | -36.09% |
| Return on Invested Capital | -77.40% |
| Profit Margin (Quarterly) | 50.86% |
| Operating Margin (Quarterly) | 48.95% |
| Return on Net Operating Assets | -169.9% |